Development of broadly reactive influenza vaccines by targeting the conserved regions of the hemagglutinin stem and head domains.

While great strides have been made in the development of universal influenza vaccine candidates, real-life use still requires improvement of stability, enhancement of their breadth of protection and ease of production, while efficacies need to be determined in human trials.